Laddar...
Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study
BACKGROUND: Two recent randomized controlled trials of type 2 diabetes mellitus (T2DM) patients with history of, or at high risk for, cardiovascular disease (CVD) showed no risk of ischemic cardiovascular events associated with dipeptidyl peptidase-4 inhibitors (DPP4i) but an increased risk of heart...
Sparad:
| I publikationen: | Acta Diabetol |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4241160/ https://ncbi.nlm.nih.gov/pubmed/25311055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00592-014-0663-2 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|